Toxicology Drug Screening Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Report Covers Toxicology Drug Screening Market Revenue, Growth Analysis and is segmented by Testing Type (In Vitro, In Vivo, and In Silico), Product (Instruments, Reagents and Consumables, Animal Models, Software, and Other Products), Application (Immunotoxicity, Systemic toxicity, Developmental and Reproductive Toxicity (DART), Endocrine Disruption, and Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The Market Size and Forecast are Provided in Terms of Value (In USD Million) for the Above Segments.

Toxicology Drug Screening Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Toxicology Drug Screening Industry Overview

The toxicology drug screening market is moderately competitive, with the presence of a few key players. Some companies currently dominating the market are Agilent Technologies Inc., Bio-Rad Laboratories Inc., Eurofins Scientific, Danaher, Laboratory Corporation of America Holdings, BioReliance Inc., Thermo Fisher Scientific Inc., and Enzo Life Sciences Inc.

Toxicology Drug Screening Market Leaders

  1. Agilent Technologies, Inc

  2. Bio-Rad Laboratories, Inc

  3. Eurofins scientific

  4. Danaher

  5. Laboratory Corporation of America Holdings

  6. *Disclaimer: Major Players sorted in no particular order
Toxicology Drug Screening Market Concentration